Evidence map›Paper›PMID 29858746›Full record

Trial reportQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2018

Long-term quality of life improvement for chronic intractable back and leg pain patients using spinal cord stimulation: 12-month results from the SENZA-RCT.

Kasra Amirdelfan, Cong Yu, Matthew W Doust, Bradford E Gliner, Donna M Morgan, Leonardo Kapural, Ricardo Vallejo, B Todd Sitzman, Thomas L Yearwood, Richard Bundschu and 6 more

Registry-linked trialOpen access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01609972 (Multi-Center, Prospective, Randomized, Controlled Clinical Trial to Demonstrate Non-Inferiority of the Senza™ Spinal Cord Stimulation), which is not on this map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01609972 naunknown statusnot on this map

Multi-Center, Prospective, Randomized, Controlled Clinical Trial to Demonstrate Non-Inferiority of the Senza™ Spinal Cord Stimulation (SCS) System in the Treatment of Chronic Pain as Compared to Commercially Available SCS Devices

TypeinterventionalSponsorNevro CorpRan2012 to 2015Enrolled356ConditionsChronic Low Back PainArmsSpinal Cord Stimulator
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Pain, quality of life, and function in chronic intractable leg pain were substantially improved with 10kHz spinal cord stimulation in a multicentre European study.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2025
    Observational
  8. Extreme pulse dosing of 10 kHz spinal cord stimulation: how low can you go?Frontiers in pain research (Lausanne, Switzerland) · 2025
    Article
  9. Review
  10. Motor improvement and spasms recovery with high-frequency 10 kHz spinal cord stimulation in a patient with spastic tetraparesis: beyond pain relief.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2024
    Article
  11. Spinal Cord Stimulation for Painful Diabetic Neuropathy.Journal of diabetes science and technology · 2024
    Review
  12. Article
  13. Article
  14. Measures of sleep disturbance are not routinely captured in trials for chronic low back pain: a systematic scoping review of 282 trials.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Kasra AmirdelfanIPM Medical Group, Inc., Walnut Creek, CA, USA.
Cong YuSwedish Pain Center, Seattle, WA, USA.
Matthew W DoustThe Pain Center of Arizona and HOPE Research Institute, Phoenix, AZ, USA.
Bradford E GlinerClinical Affairs, Nevro Corp., 1800 Bridge Parkway, Redwood City, CA, 94065, USA.
Donna M MorganPain Specialists of Oregon, Eugene, OR, USA.
Leonardo KapuralCenter for Clinical Research and Carolina's Pain Institute at Brookstown, Wake Forest Baptist Health, Winston-Salem, NC, USA.
Ricardo VallejoMillennium Pain Center, Bloomington, IL, USA.
B Todd SitzmanAdvanced Pain Therapy, PLLC, Hattiesburg, MS, USA.
Thomas L YearwoodComprehensive Pain and Rehabilitation, Pascagoula, MS, USA.
Richard BundschuCoastal Orthopedics and Pain Medicine, Bradenton, FL, USA.
Thomas YangSwedish Pain Center, Seattle, WA, USA.
Ramsin BenyaminMillennium Pain Center, Bloomington, IL, USA.
Abram H BurgherThe Pain Center of Arizona and HOPE Research Institute, Phoenix, AZ, USA.
Elizabeth S BrooksClinical Affairs, Nevro Corp., 1800 Bridge Parkway, Redwood City, CA, 94065, USA.
Ashley A PowellClinical Affairs, Nevro Corp., 1800 Bridge Parkway, Redwood City, CA, 94065, USA.
Jeyakumar SubbaroyanClinical Affairs, Nevro Corp., 1800 Bridge Parkway, Redwood City, CA, 94065, USA. jey.subbaroyan@nevro.com.
Nevro (United States) · USMillennium Pain Center · USSwedish Medical Center · USCarolinas Pain Institute · USCoastal Orthopedics · USPain and Rehabilitation Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeChronic axial low-back pain is a debilitating disorder that impacts all aspects of an afflicted individual's life. Effective, durable treatments have historically been elusive. Interventional therapies, such as spinal cord stimulation (SCS), have shown limited efficacy at best. Recently, a novel treatment, 10 kHz SCS, has demonstrated superior pain relief compared with traditional SCS in a randomized controlled trial (RCT). In this manuscript, we report on the long-term improvements in quality of life (QoL) outcomes for subjects enrolled in this study.

methodsA prospective, multicenter, randomized controlled trial (SENZA-RCT) was conducted. Patients with both chronic back and leg pain were enrolled and randomized (1:1) into 10 kHz SCS or traditional SCS treatment groups. A total of 171 subjects received a permanent SCS device implant. QoL and functionality measures were collected up to 12 months. The device remote control utilization, which is an indication of patient interaction with the device for adjustments, was collected at 24-month post-implantation.

resultsAt 12 months, a higher proportion of 10 kHz SCS subjects had marked improvement of their disability (Oswestry Disability Index) to a "moderate" or "minimal" impact on their daily function versus the control group. The subjects also reported better improvement in the Global Assessment of Functioning, Clinician Global Impression of Change, Pittsburgh Sleep Quality Index, and short-form McGill Pain Questionnaire, compared to traditional SCS subjects. The 10 kHz SCS subjects also reported far higher rates of both driving and sleeping with their device turned on, as well as reduced reliance on their programmers to adjust therapy settings.

conclusionsIn addition to superior pain relief, 10 kHz SCS provides long-term improvements in quality of life and functionality for subjects with chronic low-back and leg pain.

trial registrationClinicalTrials.gov (NCT01609972).

Indexed as

AdultAgedChronic PainFemaleHumansLow Back PainMaleMiddle AgedNeuralgiaPain ManagementPain MeasurementProspective StudiesQuality of LifeSpinal Cord StimulationSpineSurveys and Questionnaires10 kHzChronic low-back painHigh-frequency SCSLeg painNeuropathic painQuality of lifeSpinal cord stimulation

Identifiers

PMID29858746
OpenAlexW2806562086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.